Canopy Growth (CGC) stock
CGC · Canopy Growth Corporation · NASDAQ
- Market cap
- $184.6M
- Shares out
- 427.2M
What is the latest news on CGC stock?
CGC fell 8.98% to $0.4320 on Nov 20, 2026. No CGC story in the last two days; the most recent is below.
8-K - Canopy Growth Corp (0001737927) (Filer)
All CGC newsWhen does Canopy Growth report earnings?
Canopy Growth last reported on Nov 6, 2026, the date it announced on Oct 22, 2026. Before that it reported on Aug 7, 2026 and Feb 6, 2026. On that schedule the next report would come around early February 2027, with the date usually announced about 2 weeks ahead.
CGC earnings historyWho owns the most CGC stock?
Tidal Investments LLC was the largest reported holder of CGC at the end of Q2 2026, with 9,189,630 shares worth $8.7 million. Next came Morgan Stanley ($1.8 million) and Lazard Asset Management LLC ($1.8 million). In all, 212 institutions reported $28.2 million of CGC in their 13F filings.
All CGC fund holdersAre insiders buying or selling CGC?
Insiders are selling. In the last 90 days 6 insiders sold $87K of CGC in trades reported on Form 4. The latest: Theresa Yanofsky sold $14K, reported on Sep 30, 2026.
CGC insider tradesFinancial highlights
Full financials- Revenue, TTM
- C$407.88M
- Revenue growth
- +14.4%
- Net income, TTM
- -C$268.34M
- Net margin
- -65.8%
- Free cash flow, TTM
- -C$79.59M
- Cash
- C$247.34M
For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.
Latest news
25 items- SECCanopy Growth Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Canopy Growth Corp (0001737927) (Filer)
- PRCanopy Growth Reports Second Quarter Fiscal Year 2027 Financial Results; Net Revenue Growth of 22% Led by a 141% Increase in International Markets CannabisNet revenue growth of 30% in Cannabis segment 18% growth in Canada medical cannabis revenue and 17% growth in Canada adult-use cannabis revenue Company strengthens end-to-end EU GMP supply chain to facilitate further international growth Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED) (NASDAQ:CGC), a leading global company committed to bettering lives through cannabis, today announced its financial results for the three months ended September 30, 2026 ("Q2 FY2027"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. "We have made tremendous progress on our international strategy. Our inter
- SECSEC Form 10-Q filed by Canopy Growth Corporation10-Q - Canopy Growth Corp (0001737927) (Filer)
- PRCanopy Growth Announces Results of 2026 Annual General and Special Meeting of ShareholdersCanopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED) (NASDAQ:CGC), a leading global company committed to bettering lives through cannabis, today announced the voting results from its annual general and special meeting of shareholders convened on September 25, 2026, and adjourned to and reconvened on October 23, 2026 (the "Meeting"). A total of 154,837,897 common shares of the Company (the "Shares"), representing 36.60% of the issued and outstanding Shares, were voted in connection with the Meeting by the Company’s shareholders (the "Shareholders"). All of the matters put forward before the Shareholders for consideration and approval, as set out in the Com
- SECSEC Form 8-K filed by Canopy Growth Corporation8-K - Canopy Growth Corp (0001737927) (Filer)
- PRCanopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED) (NASDAQ:CGC), a leading global company committed to bettering lives through cannabis, will release its financial results for the second quarter fiscal year 2027 ended September 30, 2026, before financial markets open on November 6, 2026. Following the release of its financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO, and Tom Stewart, CFO, on November 6, 2026, at 10:00 AM Eastern Time (ET). A live audio webcast will be available at: https://onlinexperiences.com/Launch/QReg/ShowUUID=33326F1E-3AA2-4BF8-B99B-3C39D0250CC7 A replay will be accessible by webcast until 11:59 P
- SECSEC Form DEFA14A filed by Canopy Growth CorporationDEFA14A - Canopy Growth Corp (0001737927) (Filer)
- SECSEC Form 8-K filed by Canopy Growth Corporation8-K - Canopy Growth Corp (0001737927) (Filer)
- PRCanopy Growth’s Smiths Falls Facility Becomes Canada’s Only EU GMP-Certified Site Combining Softgel Manufacturing With Primary Packaging of Softgels, Oral Liquids and Dried Cannabis FlowerCertification strengthens Canopy Growth’s European growth strategy and expands its integrated EU GMP supply chainCanopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED) (NASDAQ:CGC), a leading global company committed to bettering lives through cannabis, today announced that its Smiths Falls, Ontario facility ("Smiths Falls") has received European Union Good Manufacturing Practice ("EU GMP") certification for manufacturing and packaging activities from the Tübingen Regional Council (Regierungspräsidium Tübingen), Baden-Württemberg’s competent medicines regulatory authority in Germany.Smiths Falls is now the only Canadian cannabis facility with EU GMP certificatio
- SECSEC Form DEFA14A filed by Canopy Growth CorporationDEFA14A - Canopy Growth Corp (0001737927) (Filer)
- INSIDERDirector Yanofsky Theresa sold $13,828 worth of shares (14,920 units at $0.93), decreasing direct ownership by 10% to 131,495 units (SEC Form 4) to satisfy withholding obligation4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERDirector Lazzarato David Angelo sold $20,742 worth of shares (22,380 units at $0.93), decreasing direct ownership by 11% to 189,479 units (SEC Form 4) to satisfy tax liability4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERDirector Bayern Joseph sold $2,869 worth of shares (3,096 units at $0.93), decreasing direct ownership by 2% to 142,031 units (SEC Form 4) to cover withholding tax4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDERDirector Atkins M Shan sold $2,869 worth of shares (3,096 units at $0.93), decreasing direct ownership by 2% to 143,421 units (SEC Form 4) (for withholding tax)4 - Canopy Growth Corp (0001737927) (Issuer)
- PRCanopy Growth Appoints Sebastian Blöte as Country Manager for GermanyMr. Blöte’s appointment strengthens Canopy Growth’s commercial leadership as it drives growth across its European medical cannabis businessCanopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED) (NASDAQ:CGC), a leading global company committed to bettering lives through cannabis, today announced the appointment of Sebastian Blöte as Country Manager for Germany, effective October 1, 2026.Mr. Blöte will lead Canopy Growth's commercial strategy in Germany, with responsibility for expanding sales and strengthening execution across the market, deepening connections with partners and healthcare professionals, and driving growth to fully capture the significant potentia
- SECSEC Form DEFA14A filed by Canopy Growth CorporationDEFA14A - Canopy Growth Corp (0001737927) (Filer)
- PRCanopy Growth Announces Adjournment of 2026 Annual General and Special Meeting Due to Lack of QuorumAnnual General and Special Meeting of Shareholders of Canopy Growth to reconvene on Friday, October 23, 2026, at 1:00 p.m. ET Shareholders now have until Friday, October 23, 2026, at 9:00 a.m. ET to submit their votes Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED) (NASDAQ:CGC), a leading global company committed to bettering lives through cannabis, today announced that, due to the requisite quorum not being present, its Annual General and Special Meeting of shareholders (the "Meeting"), scheduled for Friday, September 25, 2026, at 1:00 p.m. ET via live webcast, was convened and then adjourned. The Meeting will reconvene on Friday, October 23, 2
- PRCanopy Growth Announces Extension of Proxy Voting Deadline for 2026 Annual General and Special MeetingShareholders now have until Friday, September 25, 2026, at 12:00 p.m. ET to submit their votes Shareholders who need assistance can contact Sodali & Co. at 1-833-830-8205 toll free in North America, or 1-289-695-3075 collect outside North America, or by email at CGC@investor.sodali.com Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED) (NASDAQ:CGC), a leading global company committed to bettering lives through cannabis, today announced it has extended the proxy voting deadline for its upcoming Annual General and Special Meeting of shareholders (the "Meeting") to 12:00 p.m. ET on Friday, September 25, 2026. The Meeting will be held later the same da
- PRCanopy Growth Expands European Medical Cannabis Supply Into the UKFour Canadian-grown flower strains to be supplied for distribution in the UK medical cannabis market under Spectrum Therapeutics Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED) (NASDAQ:CGC), a leading global company committed to bettering lives through cannabis, today announced that it will supply four Canadian-grown medical cannabis flower strains for distribution in the United Kingdom (the "UK"), expanding the reach of its international cannabis business into another European market. The Canadian-grown flower strains will be supplied to GROW Group U.K. Ltd. ("GROW Group"), a manufacturer and distributor of prescribed cannabis-based medicines across
- INSIDEROfficer Stewart Thomas Carlton sold $23,952 worth of shares (25,755 units at $0.93), decreasing direct ownership by 4% to 588,412 units (SEC Form 4) to satisfy withholding tax4 - Canopy Growth Corp (0001737927) (Issuer)
- SECSEC Form DEFA14A filed by Canopy Growth CorporationDEFA14A - Canopy Growth Corp (0001737927) (Filer)
- PRCanopy Growth Reminds Shareholders to Vote Ahead of September 23 DeadlineShareholders are encouraged to vote now ahead of the Company’s Annual General and Special Meeting of shareholders on September 25, 2026 Votes must be submitted by 1:00pm ET on September 23, 2026, to ensure they are counted Shareholders with questions or who need assistance can contact Canopy Growth’s proxy solicitation agent, Sodali & Co. at 1-833-830-8205 toll free in North America, or 1-289-695-3075 collect outside North America, or by email at CGC@investor.sodali.com Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED) (NASDAQ:CGC), a leading global company committed to bettering lives through cannabis, today reminds shareholders to vote ahead of
- PRCanopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats and FormulationsNew pastille and all-in-one vape formats, expanded oil and softgel offerings, and new flower SKUs build on international growth momentum Canopy Growth Corporation ("Canopy Growth", "our", "we" or the "Company") (TSX:WEED) (NASDAQ:CGC), a leading global company committed to bettering lives through cannabis, today announced a broadening of its medical cannabis portfolio in Australia across its Spectrum Therapeutics, Spectrum Therapeutics Reserve, 7ACRES, Tweed and Twd. brands. The expansion introduces two new product formats, and new formulations within its existing oil and softgel ranges. "Expanding our product offering in established markets like Australia is central to our internationa
- INSIDEROfficer Gedeon Christelle sold $19,616 worth of shares (13,344 units at $1.47), decreasing direct ownership by 2% to 692,162 units (SEC Form 4) to cover taxes4 - Canopy Growth Corp (0001737927) (Issuer)
- INSIDEROfficer Stewart Thomas Carlton sold $3,280 worth of shares (2,231 units at $1.47), decreasing direct ownership by 0.36% to 614,167 units (SEC Form 4) to satisfy withholding obligation4 - Canopy Growth Corp (0001737927) (Issuer)
- SEC Filings8(32%)
- Insider7(28%)
- Other5(20%)
- Leadership3(12%)
- Earnings2(8%)
Canopy Growth Corporation (CGC) is a Medicinal Chemicals and Botanical Products company listed on NASDAQ. In the last 30 days Quantisnow tracked 5 wire items for CGC, including 3 SEC filings, 1 leadership change and 1 earnings update. The most recent was published Nov 6, 2026.
CGC FAQ
9 questionsWhat does Canopy Growth Corporation do?
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop...What is CGC revenue?
Canopy Growth Corporation (CGC) reported C$407.88M of revenue for the twelve months ended Sep 30, 2026. That is up 14.4% from the year before. Revenue for fiscal 2026 was C$346.83M.Is CGC profitable?
No. Canopy Growth Corporation reported a net loss of C$268.34M for the twelve months ended Sep 30, 2026.How much cash and debt does CGC have?
Canopy Growth Corporation reported C$247.34M in cash and cash equivalents and C$245.86M of debt on its most recent balance sheet in SEC filings.Where does CGC stock trade?
Canopy Growth Corporation (CGC) is listed on NASDAQ.What sector and industry is CGC in?
Canopy Growth Corporation operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.What are analysts saying about CGC?
Across the last 8 analyst actions on Canopy Growth Corporation, there were 3 upgrades and 2 downgrades. The most recent action was from Canaccord Genuity: Buy on 2026-03-27.What companies are similar to CGC?
Notable peers in the same industry include RLX (RLX Technology Inc.), TRLV (Trulieve Cannabis Corp. Subordinate Voting Shares), DFTX (Definium Therapeutics Inc.), CRON (Cronos Group Inc.), BTI (British American Tobacco Industries p.l.c.). Compare CGC side-by-side with any of them on Quantisnow.How can I track CGC on Quantisnow?
Quantisnow aggregates Canopy Growth Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CGC to receive live email and push alerts on every new disclosure.
Is something on this page wrong, or out of date? Request a change